SGRY EBITDA Growth
Surgery Partners Inc · EBITDA Growth
SGRY EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported81.43%period ending
SGRY TTM EBITDA YoY % (-232.34% → 81.43%)
Year-over-year change
High-resolution chart · PNG
SGRY ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 81.4283% | |
| 95.5909% | |
| 89.6091% | |
| 72.6792% | |
| 10.3528% | |
| 2.9851% | |
| 12.3963% | |
| 8.1161% | |
| 10.121% | |
| 15.3772% | |
| -3.0217% | |
| -7.6631% | |
| -6.28% | |
| -6.0392% | |
| 14.7132% | |
| 22.9432% | |
| 35.2403% | |
| 36.062% | |
| 44.3485% | |
| 48.6497% | |
| 15.3401% | |
| 7.3211% | |
| -13.5118% | |
| 41.198% | |
| 74.8751% | |
| 95.4268% | |
| 122.0287% | |
| -33.8708% | |
| -36.5115% | |
| -40.2588% | |
| -48.2339% | |
| 15.2389% | |
| 6.6748% | |
| 20.3012% | |
| 379.2371% | |
| 358.1219% | |
| 356.655% | |
| -156.8075% | |
| -167.4948% | |
| -197.4338% | |
| -232.3357% |